Testing effectiveness (Phase 2)UnknownNCT01830478What this trial is testingLenalidomide Plus Rituximab (R) in Non Follicular NHLWho this might be right forIndolent Non Hodgkin Lymphoma Gruppo Italiano Studio Linfomi 44
Early research (Phase 1)Study completedNCT03498430What this trial is testingCopanlisib Chinese PK StudyWho this might be right forLymphoma, Non-Hodgkin Bayer 13
Very early researchUnknownNCT04626739What this trial is testingCAR-T Cells in Treating Patients With Relapsed or Refractory NHLWho this might be right forRefractory Indolent Adult Non-Hodgkin Lymphoma Hebei Senlang Biotechnology Inc., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT03035331What this trial is testingDendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin LymphomaWho this might be right forAggressive Non-Hodgkin LymphomaIndolent Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma+7 more Mayo Clinic 11
Testing effectiveness (Phase 2)Study completedNCT00572013What this trial is testingRituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent LymphomaWho this might be right forLymphoma University of Nebraska 32
Early research (Phase 1)Ended earlyNCT02663518What this trial is testingA Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid TumorsWho this might be right forHematologic MalignanciesSolid Tumor Pfizer 249
Large-scale testing (Phase 3)WithdrawnNCT00551239What this trial is testingFludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaWho this might be right forLeukemiaLymphoma CTI BioPharma
Not applicableStudy completedNCT00574730What this trial is testingCHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkins Lymphoma University of Nebraska 27
Early research (Phase 1)Study completedNCT02417285What this trial is testingA Phase 1b Open-label Study to Evaluate the Safety and Efficacy of CC-122 With Obinutuzumab (GA101) in Relapsed/Refractory DLBCL and iNHL.Who this might be right forLymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin Celgene 75
Early research (Phase 1)Study completedNCT02257242What this trial is testingVincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell LymphomaWho this might be right forLymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Mantle-Cell+3 more Brown University 11
Early research (Phase 1)Study completedNCT02049541What this trial is testingStudy of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell LymphomaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+6 more Kami Maddocks, MD 18
Early research (Phase 1)Study completedNCT04578600What this trial is testingCC-486, Lenalidomide, and Obinutuzumab for the Treatment of Recurrent or Refractory CD20 Positive B-cell LymphomaWho this might be right forIndolent B-Cell Non-Hodgkin LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic Leukemia+16 more Joseph Tuscano 8
Large-scale testing (Phase 3)Study completedNCT01073163What this trial is testingStudy to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)Who this might be right forNon-Hodgkin's LymphomaMantle Cell Lymphoma Cephalon 54
Testing effectiveness (Phase 2)Looking for participantsNCT06461182What this trial is testingGa-68-CXCR4 PET/CT in Indolent B-cell LymphomaWho this might be right forIndolent B-Cell Non-Hodgkin Lymphoma Koo Foundation Sun Yat-Sen Cancer Center 15
Not applicableUnknownNCT04097067What this trial is testingISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-LymphomaWho this might be right forFollicular Lymphoma (Gastric or Duodenal)Marginal Zone Lymphoma (Gastric or Duodenal) University Hospital Muenster 83
Early research (Phase 1)Active Not RecruitingNCT04447716What this trial is testingAn Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to TreatmentWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Follicular LymphomaRecurrent Indolent Adult Non-Hodgkin Lymphoma+5 more Thomas Jefferson University 4
Large-scale testing (Phase 3)Study completedNCT00075946What this trial is testingRituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's LymphomaWho this might be right forLymphoma Eastern Cooperative Oncology Group 545
Early research (Phase 1)Looking for participantsNCT06223542What this trial is testingStudying TAK-243 in Patients With Advanced CancerWho this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmIndolent Non-Hodgkin Lymphoma+3 more National Cancer Institute (NCI) 95
Early research (Phase 1)Study completedNCT01805375What this trial is testingA Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell MalignanciesWho this might be right forIndolent B-cell LymphomaChronic Lymphocytic LeukaemiaWaldenström Macroglobulinaemia Cancer Research UK 28
Large-scale testing (Phase 3)Ended earlyNCT01289223What this trial is testingA Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab.Who this might be right forIndolent B-cell NHL Mundipharma Research Limited 88